1. Home
  2. TSHA vs DEC Comparison

TSHA vs DEC Comparison

Compare TSHA & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • DEC
  • Stock Information
  • Founded
  • TSHA 2019
  • DEC 2001
  • Country
  • TSHA United States
  • DEC United States
  • Employees
  • TSHA N/A
  • DEC N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • DEC
  • Sector
  • TSHA Health Care
  • DEC
  • Exchange
  • TSHA Nasdaq
  • DEC Nasdaq
  • Market Cap
  • TSHA 728.4M
  • DEC 696.2M
  • IPO Year
  • TSHA 2020
  • DEC N/A
  • Fundamental
  • Price
  • TSHA $2.46
  • DEC $15.06
  • Analyst Decision
  • TSHA Strong Buy
  • DEC Strong Buy
  • Analyst Count
  • TSHA 7
  • DEC 4
  • Target Price
  • TSHA $7.57
  • DEC $20.75
  • AVG Volume (30 Days)
  • TSHA 4.9M
  • DEC 449.1K
  • Earning Date
  • TSHA 08-11-2025
  • DEC 01-01-0001
  • Dividend Yield
  • TSHA N/A
  • DEC 7.68%
  • EPS Growth
  • TSHA N/A
  • DEC N/A
  • EPS
  • TSHA N/A
  • DEC N/A
  • Revenue
  • TSHA $7,224,000.00
  • DEC $758,798,000.00
  • Revenue This Year
  • TSHA N/A
  • DEC $46.42
  • Revenue Next Year
  • TSHA N/A
  • DEC $9.54
  • P/E Ratio
  • TSHA N/A
  • DEC N/A
  • Revenue Growth
  • TSHA N/A
  • DEC N/A
  • 52 Week Low
  • TSHA $1.05
  • DEC $10.08
  • 52 Week High
  • TSHA $3.31
  • DEC $17.70
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 45.90
  • DEC 64.84
  • Support Level
  • TSHA $2.48
  • DEC $14.68
  • Resistance Level
  • TSHA $2.66
  • DEC $15.09
  • Average True Range (ATR)
  • TSHA 0.21
  • DEC 0.41
  • MACD
  • TSHA -0.06
  • DEC 0.03
  • Stochastic Oscillator
  • TSHA 10.14
  • DEC 93.98

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About DEC Diversified Energy Company plc

Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.

Share on Social Networks: